|
schizophrenia |
13 |
|
covid-19 |
12 |
|
depression |
12 |
|
delusional disorder |
10 |
|
f-dopa |
10 |
|
first-episode psychosis |
10 |
|
negative symptoms |
10 |
|
positron emission tomography |
10 |
|
striatal dopamine capacity synthesis |
10 |
|
corpus striatum |
8 |
|
dopamine |
8 |
|
raclopride |
8 |
|
anxiety |
7 |
|
coping strategies |
7 |
|
correlates |
7 |
|
loneliness |
7 |
|
mental disorders |
7 |
|
network analysis |
7 |
|
pre-existing mental disorders |
7 |
|
psychiatric patients |
7 |
|
social support |
7 |
|
suicidal ideation |
7 |
|
survey |
7 |
|
coping styles |
6 |
|
meta-analysis |
6 |
|
self-reported cognitive complaints |
6 |
|
systematic review |
6 |
|
traumatic stress symptoms |
6 |
|
aged |
5 |
|
dementia |
5 |
|
transcranial direct current stimulation |
5 |
|
antidepressants |
4 |
|
children & adolescents |
4 |
|
cognitive impairment |
4 |
|
electronic health record |
4 |
|
pharmacoepidemiology |
4 |
|
prescription patters |
4 |
|
temporal trends |
4 |
|
cognitive dysfunction |
3 |
|
episodic |
3 |
|
memory |
3 |
|
mindfulness |
3 |
|
transcranial direct current stimulation (tdcs) |
3 |
|
transcranial magnetic stimulation |
3 |
|
alzheimer's disease |
2 |
|
anodal transcranial |
2 |
|
augmentation therapy |
2 |
|
brain |
2 |
|
brain stimulation |
2 |
|
cognitive function |
2 |
|
cortical thickness |
2 |
|
high-definition transcranial direct current stimulation |
2 |
|
late-life depression |
2 |
|
magnetic resonance imaging |
2 |
|
mild cognitive impairment |
2 |
|
neurocognitive disorder |
2 |
|
neuropsychological performance |
2 |
|
prefrontal cortex |
2 |
|
randomized clinical trial |
2 |
|
suicide |
2 |
|
working memory |
2 |
|
adhd |
1 |
|
adolescents |
1 |
|
attention |
1 |
|
autism spectrum disorder |
1 |
|
cognitive training |
1 |
|
efficacy |
1 |
|
neuromodulation |
1 |
|
randomized controlled trial |
1 |
|
rct |
1 |
|
transcranial pulse stimulation |
1 |
